FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

82075003: Bismuth subsalicylate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
136140019 Bismuth subsalicylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
823421011 Bismuth subsalicylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
182501000077115 sous-salicylate de bismuth fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
795251000172111 subsalicylate de bismuth fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bismuth subsalicylate Is a Product containing bismuth (medicinal product) false Inferred relationship Some
Bismuth subsalicylate Is a Bismuth compound true Inferred relationship Some
Bismuth subsalicylate Is a agent antidiarrhéique false Inferred relationship Some
Bismuth subsalicylate Is a Antacid (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing bismuth subsalicylate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth subsalicylate Inferred relationship Some 1
Product containing bismuth subsalicylate and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth subsalicylate Inferred relationship Some 3
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bismuth subsalicylate Inferred relationship Some
Product containing only bismuth subsalicylate and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth subsalicylate Inferred relationship Some 3
Product containing only bismuth subsalicylate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bismuth subsalicylate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start